Evidence map›Paper›PMID 24735871›Full record

ArticleJournal of molecular biology2014

Gly25-Ser26 amyloid β-protein structural isomorphs produce distinct Aβ42 conformational dynamics and assembly characteristics.

Robin Roychaudhuri, Aleksey Lomakin, Summer Bernstein, Xueyun Zheng, Margaret M Condron, George B Benedek, Michael Bowers, David B Teplow

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Robin RoychaudhuriDepartment of Neurology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA.
Aleksey LomakinDepartment of Physics and Center for Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Summer BernsteinDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
Xueyun ZhengDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
Margaret M CondronDepartment of Neurology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA.
George B BenedekDepartment of Physics and Center for Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Michael BowersDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
David B TeplowDepartment of Neurology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA; Molecular Biology Institute and Brain Research Institute, University of California Los Angeles, Los Angeles, CA 90095, USA. Electronic address: dteplow@ucla.edu.
University of California, Los Angeles · USUniversity of California, Santa Barbara · USMassachusetts Institute of Technology · US

Funding

STRUCTURAL/KINETIC ANALYSIS OF ABETA FIBRILLOGENESISR01NS038328 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEPLOW, DAVID B. · 1999 to 2014
$4.0M
Amyloid Beta-Protein: Wild Type and Familial Mutant Assembly and InhibitionR01AG047116 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI BOWERS, MICHAEL THOMAS · 2013 to 2016
$1.8M
HIGH-END CRYOEM INSTRUMENT FOR UCLA ELECTRON IMAGING CTR FOR NANOMACHINES: AIDSS10RR023057 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHOU, Z HONG · 2006 to 2006
$1.6M
Physical Biochemistry and Biology of Amyloid Beta-ProteinR01AG041295 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEPLOW, DAVID B. · 2011 to 2015
$1.6M
NCRR NIH HHS 1S10RR23057NCRR NIH HHS S10 RR023057NIA NIH HHS AG041295NIA NIH HHS AG047116NIA NIH HHS R01 AG041295NIA NIH HHS R01 AG047116NINDS NIH HHS NS038328NINDS NIH HHS R01 NS038328
6 · The paper itself

Abstract

One of the earliest events in amyloid β-protein (Aβ) self-association is nucleation of Aβ monomer folding through formation of a turn at Gly25-Lys28. We report here the effects of structural changes at the center of the turn, Gly25-Ser26, on Aβ42 conformational dynamics and assembly. We used "click peptide" chemistry to quasi-synchronously create Aβ42 from 26-O-acyliso-Aβ42 (iAβ42) through a pH jump from 3 to 7.4. We also synthesized Nα-acetyl-Ser26-iAβ42 (Ac-iAβ42), which cannot undergo O→N acyl chemistry, to study the behavior of this ester form of Aβ42 itself at neutral pH. Data from experiments monitoring increases in β-sheet formation (thioflavin T, CD), hydrodynamic radius (RH), scattering intensity (quasielastic light scattering spectroscopy), and extent of oligomerization (ion mobility spectroscopy-mass spectrometry) were quite consistent. A rank order of Ac-iAβ42>iAβ42>Aβ42 was observed. Photochemically cross-linked iAβ42 displayed an oligomer distribution with a prominent dimer band that was not present with Aβ42. These dimers also were observed selectively in iAβ42 in ion mobility spectrometry experiments. The distinct biophysical behaviors of iAβ42 and Aβ42 appear to be due to the conversion of iAβ42 into "pure" Aβ42 monomer, a nascent form of Aβ42 that does not comprise the variety of oligomeric and aggregated states present in pre-existent Aβ42. These results emphasize the importance of the Gly25-Ser26 dipeptide in organizing Aβ42 monomer structure and thus suggest that drugs altering the interactions of this dipeptide with neighboring side-chain atoms or with the peptide backbone could be useful in therapeutic strategies targeting formation of Aβ oligomers and higher-order assemblies.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBiophysical PhenomenaClick ChemistryGlycineHumansMolecular Dynamics SimulationPeptide FragmentsProtein ConformationProtein FoldingProtein IsoformsProtein MultimerizationSerineAmyloid beta-Peptidesamyloid beta-protein (1-42)GlycinePeptide FragmentsProtein IsoformsSerineAlzheimer's diseaseamyloid β-proteinfibril formationion mobility spectroscopy–mass spectrometryoligomerization

Identifiers

PMID24735871
PMCPMC4191920
OpenAlexW2056241835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.